Vistagen Therapeutics Inc (VTGN)
4.55
-0.04
(-0.87%)
USD |
NASDAQ |
May 16, 16:00
4.68
+0.13
(+2.86%)
After-Hours: 05:53
Vistagen Therapeutics Shareholders Equity (Quarterly): 123.28M for Dec. 31, 2023
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
Date | Value |
---|---|
December 31, 2023 | 123.28M |
September 30, 2023 | 35.65M |
June 30, 2023 | 6.849M |
March 31, 2023 | 12.08M |
December 31, 2022 | 20.67M |
September 30, 2022 | 29.60M |
June 30, 2022 | 46.05M |
March 31, 2022 | 64.72M |
December 31, 2021 | 79.98M |
September 30, 2021 | 80.66M |
June 30, 2021 | 85.62M |
March 31, 2021 | 91.98M |
December 31, 2020 | 93.81M |
September 30, 2020 | 4.223M |
June 30, 2020 | -5.612M |
March 31, 2020 | -5.729M |
December 31, 2019 | -6.095M |
September 30, 2019 | -3.630M |
June 30, 2019 | 1.626M |
March 31, 2019 | 7.075M |
December 31, 2018 | 1.693M |
September 30, 2018 | 3.989M |
June 30, 2018 | 3.222M |
March 31, 2018 | 6.917M |
December 31, 2017 | 10.26M |
Date | Value |
---|---|
September 30, 2017 | -1.672M |
June 30, 2017 | -0.6068M |
March 31, 2017 | 0.6158M |
December 31, 2016 | 2.589M |
September 30, 2016 | 4.087M |
June 30, 2016 | 6.162M |
March 31, 2016 | -2.977M |
December 31, 2015 | -1.598M |
September 30, 2015 | -1.325M |
June 30, 2015 | -2.866M |
March 31, 2015 | -20.54M |
December 31, 2014 | -17.78M |
September 30, 2014 | -17.37M |
June 30, 2014 | -15.39M |
March 31, 2014 | -12.80M |
December 31, 2013 | -11.67M |
September 30, 2013 | -12.75M |
June 30, 2013 | -11.95M |
March 31, 2013 | -12.56M |
December 31, 2012 | -10.52M |
September 30, 2012 | -6.458M |
June 30, 2012 | -6.284M |
March 31, 2012 | -5.706M |
December 31, 2011 | -4.762M |
September 30, 2011 | -8.724M |
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
-6.095M
Minimum
Dec 2019
123.28M
Maximum
Dec 2023
39.78M
Average
29.60M
Median
Sep 2022
Shareholders Equity (Quarterly) Benchmarks
Ardelyx Inc | 150.89M |
Axsome Therapeutics Inc | 144.04M |
Vir Biotechnology Inc | 1.547B |
Immuneering Corp | 78.72M |
NovaBay Pharmaceuticals Inc | 0.16M |
Shareholders Equity (Quarterly) Related Metrics
Total Assets (Quarterly) | 131.07M |
Total Liabilities (Quarterly) | 7.783M |
Current Ratio | 30.76 |
Net Debt Paydown Yield | 0.11% |